- Home
- HSON vs NRXP Comparison
HSON vs NRXP Comparison
Compare HSON & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSON
- NRXP
- Stock Information
- Founded
- HSON 1999
- NRXP 2015
- Country
- HSON United States
- NRXP United States
- Employees
- HSON N/A
- NRXP N/A
- Industry
- HSON Professional Services
- NRXP Biotechnology: Pharmaceutical Preparations
- Sector
- HSON Consumer Discretionary
- NRXP Health Care
- Exchange
- HSON Nasdaq
- NRXP Nasdaq
- Market Cap
- HSON 23.1M
- NRXP 58.5M
- IPO Year
- HSON N/A
- NRXP N/A
- Fundamental
- Price
- HSON $9.03
- NRXP $2.84
- Analyst Decision
- HSON
- NRXP Strong Buy
- Analyst Count
- HSON 0
- NRXP 4
- Target Price
- HSON N/A
- NRXP $28.50
- AVG Volume (30 Days)
- HSON 9.5K
- NRXP 137.7K
- Earning Date
- HSON 08-07-2025
- NRXP 08-13-2025
- Dividend Yield
- HSON N/A
- NRXP N/A
- EPS Growth
- HSON N/A
- NRXP N/A
- EPS
- HSON N/A
- NRXP N/A
- Revenue
- HSON $138,031,000.00
- NRXP N/A
- Revenue This Year
- HSON $0.80
- NRXP N/A
- Revenue Next Year
- HSON $8.09
- NRXP $230.95
- P/E Ratio
- HSON N/A
- NRXP N/A
- Revenue Growth
- HSON N/A
- NRXP N/A
- 52 Week Low
- HSON $8.26
- NRXP $1.10
- 52 Week High
- HSON $18.48
- NRXP $6.01
- Technical
- Relative Strength Index (RSI)
- HSON 61.11
- NRXP 38.54
- Support Level
- HSON $8.77
- NRXP $2.89
- Resistance Level
- HSON $9.19
- NRXP $3.15
- Average True Range (ATR)
- HSON 0.34
- NRXP 0.14
- MACD
- HSON 0.09
- NRXP -0.04
- Stochastic Oscillator
- HSON 62.90
- NRXP 10.22
About HSON Hudson Global Inc.
Hudson Global Inc provides specialized recruitment and related talent solutions. Its core services include Permanent recruitment, Contracting, Recruitment process outsourcing (RPO) and Talent management solutions. Its Permanent recruitment services leverage the company's consultants. In contracting services, it offers project management, interim management and professional contract staffing services. RPO services deliver permanent and contracting outsourced recruitment solutions to various companies whereas, Talent management solutions feature services like talent assessment, interview training, executive coaching, employee development and outplacement.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.